GT Biopharma, Inc.GTBPNASDAQ
Loading
Current Ratio Over TimeElevated
Percentile Rank100
3Y CAGR+1.4%
5Y CAGR+85.0%
Year-over-Year Change
Current ratio (current assets / current liabilities)
3Y CAGR
+1.4%/yr
vs +378.2%/yr prior
5Y CAGR
+85.0%/yr
Recent deceleration
Acceleration
-376.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
21.7x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.50 | +387.5% |
| 2024 | 0.72 | -66.2% |
| 2023 | 2.12 | -36.8% |
| 2022 | 3.35 | +7.0% |
| 2021 | 3.14 | +1843.9% |
| 2020 | 0.16 | +1060.1% |
| 2019 | 0.01 | +116.7% |
| 2018 | 0.01 | -97.0% |
| 2017 | 0.22 | +19300.7% |
| 2016 | 0.00 | - |